Rep. Lisa C. McClain Sells Off Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Representative Lisa C. McClain (R-Michigan) recently sold shares of Option Care Health, Inc. (NASDAQ:OPCH). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Option Care Health stock on October 31st. The trade occurred in the Representative’s “CHARLES SCHWAB 401K > SCHWAB 893” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Option Care Health Stock Down 0.6%

OPCH stock traded down $0.20 during midday trading on Wednesday, hitting $31.02. The company’s stock had a trading volume of 1,433,942 shares, compared to its average volume of 1,930,594. The company’s fifty day moving average price is $27.87 and its 200 day moving average price is $29.41. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. Option Care Health, Inc. has a twelve month low of $22.29 and a twelve month high of $35.53. The stock has a market capitalization of $4.92 billion, a P/E ratio of 24.82, a PEG ratio of 1.74 and a beta of 0.88.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of the stock in a transaction dated Monday, November 3rd. The stock was bought at an average price of $25.98 per share, for a total transaction of $987,240.00. Following the purchase, the director directly owned 413,390 shares of the company’s stock, valued at $10,739,872.20. The trade was a 10.12% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Norman L. Wright bought 3,411 shares of the company’s stock in a transaction that occurred on Tuesday, September 9th. The shares were bought at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the transaction, the director directly owned 15,501 shares in the company, valued at $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently bought and sold shares of the company. USA Financial Formulas acquired a new stake in Option Care Health during the 2nd quarter worth about $26,000. Cornerstone Planning Group LLC increased its holdings in Option Care Health by 7,621.4% in the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after purchasing an additional 1,067 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock valued at $31,000 after buying an additional 836 shares during the period. Advisory Services Network LLC acquired a new position in Option Care Health in the third quarter valued at approximately $35,000. Finally, McIlrath & Eck LLC bought a new position in shares of Option Care Health during the 2nd quarter worth approximately $37,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Citizens Jmp lowered their price target on Option Care Health from $38.00 to $36.00 and set a “market outperform” rating on the stock in a research report on Friday, October 31st. Barrington Research restated an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a research note on Friday, October 31st. Weiss Ratings reiterated a “hold (c-)” rating on shares of Option Care Health in a research report on Tuesday. Cowen began coverage on shares of Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating on the stock. Finally, Wall Street Zen downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Nine research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $35.67.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.